Lavipharm Dividends and Buybacks
Dividend criteria checks 0/6
Lavipharm does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-40.9%
Buyback Yield
| Total Shareholder Yield | -40.9% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Lavipharm's (ATH:LAVI) Earnings Aren't As Good As They Appear
Sep 26
Some Shareholders Feeling Restless Over Lavipharm S.A.'s (ATH:LAVI) P/E Ratio
Aug 06Here's Why Lavipharm (ATH:LAVI) Has A Meaningful Debt Burden
Nov 01We're Not Counting On Lavipharm (ATH:LAVI) To Sustain Its Statutory Profitability
Feb 11Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if LAVI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if LAVI's dividend payments have been increasing.
Dividend Yield vs Market
| Lavipharm Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (LAVI) | n/a |
| Market Bottom 25% (GR) | 2.1% |
| Market Top 25% (GR) | 5.8% |
| Industry Average (Pharmaceuticals) | 2.5% |
| Analyst forecast (LAVI) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate LAVI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate LAVI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate LAVI's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as LAVI has not reported any payouts.